AQW 48018/22-27 Written question to the Minister of Health
To ask the Minister of Health (i) whether his Department will endorse the National Institute for Health and Care Excellence approval of mirvetuximab soravtansine (for the treatment of platinum-resistant ovarian cancer; and (ii) to detail any steps that are being taken to ensure timely access for eligible patients.
Asked by Connie Egan MLA on 5 June 2026
- Past due date
- Written
- Priority
- Tabled
- 5 June 2026
- Answer due by
- 10 June 2026
- Answered
- Not yet answered
- Department
- Department of Health
- Priority question
- Yes
Answer
No answer has been published yet. The answer is due by 10 June 2026.